Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its second fiscal quarter ended August 28, 2021. For the second quarter, the company reported net loss from continuing operations of $100.3 million, or $1.86 loss per share, Adjusted net loss from continuing operations of $22.0 million, or $0.41 loss per share, and Adjusted EBITDA from continuing operations of $106.2 million, or 1.7 percent of revenues. “We are pleased with our second quarter

Rite Aid Corporation Reports Fiscal 2022 Second Quarter Results and Raises Full Year Adjusted EBITDA Guidance

BlackBerry

The first earnings reports we have covered for this week are coming after Tuesday's closing bell and before Wednesday's open: Adobe, FedEx, General Mills and Stitch Fix.

Earnings Previews: BlackBerry, Rite Aid

Rite Aid (RAD) is likely to have gained from PBM, RxEvolution strategy and expanded omnichannel services in Q2. Rising wage costs and drab front-end same-store sales are likely to have been concerns.

Rite Aid (RAD) to Report Q2 Earnings: What Should You Know?

Adobe

AutoZone

Costco

General Mills

NIKE

Stitch Fix

Wall Street can expect a busy start to the latter part of September as this week is packed full of economic data.

Today's Stock Market News & Events: 9/20/2021

Rite Aid (RAD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Rite Aid (RAD) Q2 Earnings Expected to Decline

Clear Secure

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced a partnership with CLEAR (NYSE: YOU), the secure identity company, to offer Rite Aid customers the ability to access and share their proof of COVID-19 vaccination with CLEAR's digital vaccine card and Health Pass. Customers vaccinated at any Rite Aid location can supplement their paper vaccination card with a verified digital version accessible on their mobile device. The secure digital vaccine card can be linked to CLEAR's H

Rite Aid Partners With CLEAR to Offer Digital Vaccine Card

Rite Aid is moving its headquarters to Philadelphia in what it calls a site “designed specifically for in-person collaboration and company gatherings, rather than office spaces.” The new “enterprise headquarters” will be located in the former Navy Yard in south Philadelphia, offering a space for teams across Rite Aid's various businesses — including Rite Aid.

Rite Aid moving HQ to Philadelphia amid push for ‘collaborative' spaces

PHILADELPHIA--(BUSINESS WIRE)--Today, Rite Aid (NYSE: RAD) unveiled its corporate workplace of the future – a remote-first work approach for corporate associates, supported by a network of collaboration centers throughout the company's geographic footprint. The reimagined workplace model focuses on flexibility for associates, while also creating an official headquarters space in Philadelphia designed specifically for in-person collaboration and company gatherings, rather than office spaces. Rit

Rite Aid Brings Together Corporate Workforce Through Remote-First Collaboration

CAMP HILL, Pa.--(BUSINESS WIRE)--Elixir, a wholly owned subsidiary of Rite Aid (NYSE: RAD) that provides pharmacy benefits and services, today announced that veteran healthcare and pharmacy executive Lance Neill has joined the company as chief operating officer. Neill was most recently vice president of network development and contracting for Centene's portfolio of managed care products, representing $32 billion in annual pharmacy spend. Prior to that, he served in multiple senior leadership ro

Lance Neill Joins Elixir as New Chief Operating Officer

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE:RAD) said today that it will release financial results for its Fiscal 2022 Second Quarter, which ended Aug. 28, 2021, on Thursday, Sept. 23, 2021. The company will hold an analyst call at 8:30 a.m. Eastern Time with remarks by Rite Aid's management team. The call will be broadcast via the Internet at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. Eastern Time on Thursday, Sept. 23, 2021 an

Rite Aid to Release Second Quarter Results on September 23

OPKO Health

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced a ‘Back to School' COVID-19 testing program offering students at New York State public schools the opportunity for free COVID-19 testing prior to or at the start of the 2021-2022 school year. Students will be tested using highly accurate RT-PCR laboratory-based COVID-19 tests. To participat

Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School' COVID-19 Testing Program

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) announced today that it has entered into an amendment to its senior secured credit agreement, which, after giving effect to the amendment, consists of a $2.8 billion senior secured asset-based revolving credit facility and a $350 million “first-in, last out” senior secured term loan facility. The new facilities extend the Company's debt maturity profile and provides improved pricing on the “first-in, last out” senior secured term

Rite Aid Announces Successful Amendment and Extension to Credit Agreement

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) announced the availability of flu vaccines at all stores beginning today. Additionally, by expanding its COVID-19 online scheduling tool to include flu and ancillary vaccinations, Rite Aid now offers online scheduling in addition to walk-in availability for flu shots. Following CDC warnings that influenza infection rates could return to pre-pandemic levels this flu season, Rite Aid is making it as simple and convenient as possible to get the

Rite Aid Announces Availability of Flu Vaccines at All Locations

BIRMINGHAM, Ala., Aug. 5, 2021 /PRNewswire/ -- Same-day delivery service Shipt and Rite Aid (NYSE: RAD) today announced a partnership to bring same-day delivery of health and wellness products to Rite Aid's retail footprint across 17 states.

Shipt, Rite Aid Announce Same-Day Delivery Partnership

CHICAGO & CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid has selected dunnhumby, the global leader in customer data science, as its strategic partner to revamp its price, promotion and loyalty programs. Rite Aid and dunnhumby are utilizing customer data models and consumer-led insights to optimize these investments to improve customer value perception digitally and at more than 2,500 stores in 17 states. Rite Aid's loyalty program will be completely reimagined to deliver improved value for customers

Rite Aid Partners with dunnhumby to Revamp Price, Promotion and Loyalty Programs

CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid will launch its 27th annual customer fundraising campaign supporting Children's Miracle Network Hospitals in August.

Rite Aid Rallies for Children's Miracle Network Hospitals

Shares of the drugstore chain gained on what looked like a short squeeze.

Why Rite Aid Stock Is Climbing This Week

Bio-Rad Laboratories

The stock price of Bio-Rad Laboratories, a life science research and clinical diagnostic products company, has seen a 10% rise over the last twenty-one trading days, while it is up 30% over the last year, driven by positive developments for the company. Last month, Bio-Rad announced its partnership.

What's Next For Bio-Rad Laboratories Stock After A 10% Rise In A Month?

LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF), through its empowerDX subsidiary, and Rite Aid announce the launch of an over-the-counter, FDA-authorised[1], at-home COVID-19 PCR Test Kit. The co-branded kits, available at all Rite Aid stores across 17 states in the USA, will offer customers a convenient way to test for the virus from their home and will detect the virus in symptomatic and asymptomatic patients. The at-home COVID-19 nasal PCR kit is among the first over-the-counter at-home t

Eurofins and Rite Aid Launch an Over-the-Counter, FDA-Authorised, at-Home COVID-19 PCR Test in all Rite Aid Locations in the U.S.

Bear of the Day: Rite Aid (RAD)

Manchester United

A diverse collection of companies are have their earnings reports next week, which should provide insights into the economic reopening. The post 3 Earnings Reports to Watch Next Week appeared first on InvestorPlace.

3 Earnings Reports to Watch Next Week

The retail sector was among the hardest hit by the COVID-19 pandemic, but one subsection emerged relatively unscathed: pharmacies. According to a report from foot traffic analytics firm Placer.ai, the pharmacy sector is now showing strong growth.

Placer.ai: Rite Aid could see ‘signficant' benefits from recent momentum

AbbVie

AmerisourceBergen

Cardinal Health

CVS Health

Endo International

Johnson & Johnson

McKesson

Teva Pharmaceutical

Walgreens

Walmart

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), Endo International Plc (NASDAQ: ENDP), and AbbVie Inc's (NYSE: ABBV) Allergan misleadingly marketed opioid drugs as having a low addiction risk, a lawyer for a New York county told jurors, urging them to hold the companies liable. Jayne Conroy, representing Suffolk County, also said that the drug distributors - AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and McKesson Corp (NYSE: MCK) failed to report suspicious opioid orders as required.

New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid

Rite Aid Corp. stock sank 5.7% in Friday trading after the stock was downgraded to underweight from neutral at JPMorgan. Analysts slashed their price target to $12 from $21.

Rite Aid stock slumps 18% for the week as weak outlook, diminished vaccine tailwind drive JPMorgan downgrade

Rite Aid's (RAD) Q1 results gain from accelerated vaccinations, the RxEvolution strategy and robust online growth.

News for Rite Aid Stock (RAD)